2,016.50
+2.36%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dr. Lal PathLabs
Its shares trade on NSE under the ticker LALPATHLAB.NS. It has been listed since 23 December 2015. In the fiscal year to 31 March 2026, it reported revenue of ₹27.63bn and net income of ₹5.05bn. At that date it held total assets of ₹31.46bn and shareholders' equity of ₹25.08bn.
Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. The company is headquartered in Gurgaon, Haryana. The company went IPO on 2015-12-23. The firm is also engaged in running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, and other pathological and radiological investigations. The firm offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, Dr. Lal PathLabs Nepal Private Limited, Dr. Lal PathLabs Bangladesh Pvt. Ltd. and Dr. Lal Ventures Private Limited.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 23 Dec 2015
- Employees
- 4,110
- Website
- lalpathlabs.com ↗
Leadership
Pay as last reported
- Dr. Brig. Arvind LalExecutive Chairman of the Board, since 2020₹32.2m
- Mr. Shankha BanerjeeChief Executive Officer
- Mr. Ved GoelGroup Chief Financial Officer and Chief Executive Officer - International Business
- Mr. Jai MeenaChief Operating Officer
- Mr. Manoj GargGroup Chief Human Resources Officer
- Mr. Munender SopernaGroup Chief Information and Digital Officer
- Mr. Vinay GujralCompliance Officer, Company Secretary
- Dr. Vandana LalWhole-Time Director, since 1995₹25.8m
- Shri. Arun DuggalLead Non-Executive Independent Director₹9.3m
- Dr. Archana ErdmannNon-Executive Director₹4.4m
- Mr. Rahul SharmaNon-Executive Director₹4.8m
- Mr. Rohit BhasinNon-Executive Independent Director₹5.9m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 75
- Environment
- 77
- Social
- 81
- Governance
- 66
- Direct emissions (scope 1)
- 1,192 t
- Energy emissions (scope 2)
- 15,793 t
- Women in the workforce
- 25.98394%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dr. Lal PathLabs Ltd has established a strong brand presence in the healthcare industry, recognized for its reliability and accuracy in diagnostic testing. Its extensive network of laboratories and collection centers allows for a wide reach and convenient accessibility for patients.
- The company possesses advanced technological capabilities and constantly invests in research and development to stay at the forefront of medical advancements. This enables them to offer a comprehensive range of advanced diagnostic tests and services.
Weaknesses
- Dr. Lal PathLabs Ltd may face challenges in maintaining consistent quality control across all its laboratories and collection centers. As the company expands, ensuring standardized processes and procedures becomes increasingly crucial to avoid any lapse in accuracy or reliability.
- There is a dependency on skilled personnel and medical professionals to perform the diagnostic tests and analyze the results. The availability and retention of skilled employees pose a potential weakness if there is a shortage in the job market or if competitors offer more attractive compensation packages.
Opportunities
- Dr. Lal PathLabs Ltd can capitalize on the rising demand for preventive healthcare services and the increased awareness about the importance of early diagnosis. By offering comprehensive health check-up packages and promoting regular screening, the company can expand its customer base and revenue streams.
- With the advancements in technology and telemedicine, there is an opportunity to explore remote diagnostic testing and online consultations. This can enhance convenience for patients and open up new markets beyond the traditional brick-and-mortar setup, especially in rural areas with limited access to healthcare facilities.
Threats
- The competitive landscape in the diagnostic industry is intense, with various established players and new entrants constantly emerging. Dr. Lal PathLabs Ltd needs to adapt and differentiate itself through continuous innovation, exceptional customer service, and strategic partnerships to mitigate the threat of losing market share.
- Regulatory changes and compliance requirements can pose challenges to the company's operations. Strict adherence to government regulations and evolving healthcare policies is essential to avoid any penalties or disruptions in service delivery.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.